Sinocelltech Group (SHSE:688520) Net Change in Cash : ¥-206 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Sinocelltech Group's Net Change in Cash for the three months ended in Mar. 2024 was ¥46 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-206 Mil.

Sinocelltech Group Net Change in Cash Historical Data

The historical data trend for Sinocelltech Group's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Net Change in Cash Chart

Sinocelltech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

156.89

786.48

-600.79

621.57

-677.69

Sinocelltech Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-425.73	4.87	-141.11	-115.71	46.41

Sinocelltech Group Net Change in Cash Calculation

Sinocelltech Group's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-383.369	+	-502.793	+	208.504	+	-0.029
	=	-678

Sinocelltech Group's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 174.614 + -122.647 + -5.549 + -0.013

= 46

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-206 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinocelltech Group Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Sinocelltech Group's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinocelltech Group (SHSE:688520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Net Change in Cash

Comparable Companies

SZSE:301301 SHSE:688278 SZSE:301207 SZSE:300009 SZSE:000403 SHSE:688578 SHSE:603233 SHSE:688166 SHSE:688639 SHSE:688177 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

N/A

Address

Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176

Website

http://www.sinocelltech.com

Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Executives

Xie Liang Zhi Director

Sinocelltech Group (SHSE:688520) Headlines

No Headlines